Skip to content

“A Human Application Test to Evaluate the Suitability for Acne-Prone Skin, Sebum Reduction, Skin Barrier Improvement, and Skin Hydration Enhancement of ‘CURECODE Adapinoid Purifying Serum’”

“A Human Application Test to Evaluate the Suitability for Acne-Prone Skin, Sebum Reduction, Skin Barrier Improvement, and Skin Hydration Enhancement of ‘CURECODE Adapinoid Purifying Serum’”

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011282
Enrollment
20
Registered
2025-12-09
Start date
2025-08-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Human Application Test of a Cosmetic Product (Evaluation of Skin Tolerance, Sebum Reduction, Skin Barrier Improvement, and Hydration Improvement of the Adapinoid Purifying Serum)) : The interve
therefore, no differences exist between intervention groups. All participants followed the same intervention protocol, with no modifications in dosage or application frequency throughout the study. E

Sponsors

SKINMED
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Male or female subjects aged 19 to 40 years Individuals with facial acne lesions corresponding to IGA grades 2–3 Subjects who voluntarily agree to participate after receiving a full explanation of the study Subjects willing to comply with restrictions on the use of other skincare products during the test period

Exclusion criteria

Exclusion criteria: Subjects with severe acne or significant dermatologic disease other than acne Use of acne treatments (topical or systemic), steroids, or retinoids within 2 weeks prior to study initiation Subjects who received dermatological procedures such as laser, peeling, or acne extraction within the last 4 weeks Known history of allergy or hypersensitivity to the test product or its ingredients Pregnant or breastfeeding women Individuals deemed unsuitable for study participation by the investigator

Design outcomes

Primary

MeasureTime frame
Change in IGA (Investigator’s Global Assessment) grade

Secondary

MeasureTime frame
Evaluation of skin barrier function using TEWL measured by Tewameter;Change in ASI (Acne Severity Index) score;Change in inflammatory acne lesion count;Change in non-inflammatory acne lesion count;Assessment of facial sebum secretion using Visioscan and Sebufix (Immediate Sebum Secretion Rate);Assessment of facial skin hydration using Corneometer

Countries

Korea, Republic of

Contacts

Public ContactMINYEOUL CHANG

SKINMED

mychang195@gmail.com+82-42-5118-8437

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026